Sagimet Biosciences Inc. (SGMT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$5.11
Day's range
$5.41

Sagimet Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 6.58 M $50.83 M   722.03% 12.38%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 3.63 M $28.03 M   100.00% 6.83%
WOODLINE PARTNERS LP 08/14/2026 3.00 M $23.20 M   199.78% 5.65%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 2.93 M $22.63 M   100.00% 5.51%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.57 M $19.84 M   133.53% 4.83%
BVF INC/IL 08/14/2026 2.50 M $19.33 M   100.00% 4.71%
CALIGAN PARTNERS LP 08/14/2026 2.50 M $19.33 M   100.00% 4.71%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 2.50 M $19.31 M   187.77% 4.70%
FEDERATED HERMES, INC. 08/12/2026 2.09 M $16.13 M   267,085.02% 3.93%
GREAT POINT PARTNERS LLC 08/14/2026 2.03 M $15.69 M   100.00% 3.82%
STATE STREET CORP 08/07/2026 2.00 M $15.42 M   1,449.13% 3.76%
SATURN V CAPITAL MANAGEMENT LLC 08/14/2026 1.48 M $11.44 M   100.00% 2.79%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.44 M $11.17 M   366.53% 2.72%
BLUE OWL CAPITAL HOLDINGS LP 08/11/2026 1.26 M $9.74 M   277.55% 2.37%
BAKER BROS. ADVISORS LP 08/14/2026 953.00 K $7.37 M   0.00% 1.79%
MILLENNIUM MANAGEMENT LLC 08/14/2026 937.03 K $7.24 M   8.67% 1.76%
ABRDN PLC 07/31/2026 847.70 K $6.55 M   100.00% 1.60%
GOLDMAN SACHS GROUP INC 08/14/2026 759.09 K $5.87 M   348.48% 1.43%
HHLR ADVISORS, LTD. 08/14/2026 724.80 K $5.60 M   0.00% 1.36%
AMERIPRISE FINANCIAL INC 08/14/2026 581.22 K $4.49 M   100.00% 1.09%
VESTAL POINT CAPITAL, LP 08/14/2026 535.45 K $4.14 M   100.00% 1.01%
NORTHERN TRUST CORP 08/13/2026 468.39 K $3.62 M   743.77% 0.88%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 464.10 K $3.59 M   100.00% 0.87%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 437.50 K $3.38 M   100.00% 0.82%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 415.00 K $3.21 M   100.00% 0.78%
SEVEN FLEET CAPITAL MANAGEMENT LP 08/17/2026 403.55 K $3.12 M   100.00% 0.76%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 403.48 K $3.12 M   100.00% 0.76%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 400.84 K $3.10 M   146.49% 0.75%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 397.97 K $3.08 M   46.74% 0.75%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 346.93 K $2.68 M   -44.53% 0.65%
ATOM INVESTORS LP 08/14/2026 346.02 K $2.67 M   100.00% 0.65%
UBS GROUP AG 08/13/2026 339.93 K $2.63 M   15.65% 0.64%
RAYMOND JAMES FINANCIAL INC 08/14/2026 332.02 K $2.57 M   4.56% 0.63%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 289.30 K $2.24 M   160.63% 0.54%
PALO ALTO INVESTORS LP 08/19/2026 250.00 K $1.93 M   100.00% 0.47%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 250.00 K $1.93 M   100.00% 0.47%
BARCLAYS PLC 08/14/2026 227.93 K $1.76 M   730.99% 0.43%
PALE FIRE CAPITAL SE 08/13/2026 221.88 K $1.72 M   0.00% 0.42%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 221.54 K $1.71 M   -26.06% 0.42%
BANK OF NEW YORK MELLON CORP 08/06/2026 200.65 K $1.55 M   100.00% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 186.40 K $1.44 M   113.27% 0.35%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 175.87 K $1.36 M   1,072.48% 0.33%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 175.87 K $1.36 M   100.00% 0.33%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 166.67 K $1.29 M   100.00% 0.31%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 166.67 K $1.29 M   100.00% 0.31%
BANK OF AMERICA CORP /DE/ 08/14/2026 143.68 K $1.11 M   227.61% 0.27%
NUVEEN, LLC 08/11/2026 140.64 K $1.09 M   100.00% 0.26%
CITADEL ADVISORS LLC 09/02/2026 133.90 K $1.04 M   76.88% 0.25%
PROPEL BIO MANAGEMENT, LLC 08/13/2026 125.88 K $973.04 K   100.00% 0.24%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 120.04 K $927.88 K   420.40% 0.23%

Sagimet Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 157 institutional investors and hedge funds held shares of Sagimet Biosciences Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 6.58 M

BALYASNY ASSET MANAGEMENT L.P.: 3.63 M

Woodline Partners LP: 3 M

SILVERARC CAPITAL MANAGEMENT, LLC: 2.93 M

VANGUARD CAPITAL MANAGEMENT LLC: 2.57 M

BVF INC/IL: 2.5 M

96.38% of Sagimet Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 53.75 M shares in the last 24 months. This purchase volume represents approximately $289.16 M in transactions.